Hongbin Xu

3.1k total citations · 1 hit paper
102 papers, 2.1k citations indexed

About

Hongbin Xu is a scholar working on Surgery, Emergency Medicine and Oncology. According to data from OpenAlex, Hongbin Xu has authored 102 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Surgery, 20 papers in Emergency Medicine and 19 papers in Oncology. Recurrent topics in Hongbin Xu's work include Intraperitoneal and Appendiceal Malignancies (24 papers), Appendicitis Diagnosis and Management (20 papers) and Ovarian cancer diagnosis and treatment (16 papers). Hongbin Xu is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (24 papers), Appendicitis Diagnosis and Management (20 papers) and Ovarian cancer diagnosis and treatment (16 papers). Hongbin Xu collaborates with scholars based in China, Australia and United States. Hongbin Xu's co-authors include Yong Gan, Zuxun Lu, Heng Jiang, Chao Wang, Yudi Yang, Kai Lu, Fujian Song, Jianxin Liu, Sampson Opoku and Shijiao Yan and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hongbin Xu

96 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of workplace violence against healthcare workers: a systematic review and meta-analysis

2019 524 citations Yong Gan, Heng Jiang et al. profile →

Peers

Countries citing papers authored by Hongbin Xu

Since Specialization

Citations

This map shows the geographic impact of Hongbin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbin Xu more than expected).

Fields of papers citing papers by Hongbin Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongbin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbin Xu. The network helps show where Hongbin Xu may publish in the future.

Co-authorship network of co-authors of Hongbin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongbin Xu. A scholar is included among the top collaborators of Hongbin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongbin Xu. Hongbin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimal peritoneal cancer index cutoff point for predicting surgical resectability of pseudomyxoma peritonei in treatment-naive patients 2024 ·World Journal of Surgical Oncology ·(unknown), Yunxiang Li, (unknown), (unknown), Jingliang Chen, Hongbin Xu, Hongjiang Wei, (unknown), (unknown), Jing Feng	2
2	A study on molecular mechanism of Xihuang pill in the treatment of glioblastoma based on network pharmacology and validation in vitro and in vivo 2023 ·Journal of Ethnopharmacology ·Hongbin Xu, Xianzhen Chen, (unknown), Fei Xue, Yuanbin Zhang	0
3	Associations of maternal exposure to multiple plasma trace elements with the prevalence of fetal congenital heart defects: A nested case-control study 2023 ·The Science of The Total Environment ·Zhiqiang Nie, Hongbin Xu, Min Qiu, (unknown), Chu Chu, Michael S. Bloom, Yanqiu Ou	5
4	Prognostic value of the ascites characteristics in pseudomyxoma peritonei originating from the appendix 2023 ·Frontiers in Surgery ·Bing Wang, (unknown), (unknown), (unknown), (unknown), Shuai Lu, (unknown), Yuying Wang, Benqiang Rao, Hongbin Xu	0
5	Isolation and identification of Tete virus group (Peribunyaviridae: Orthobunyavirus) from Culicoides biting midges collected in Lichuan County, China 2023 ·Frontiers in Cellular and Infection Microbiology ·(unknown), Rui Cheng, (unknown), Ziqian Xu, Jing Wang, Shihong Fu, Hongbin Xu, (unknown), Ying He, Fan Li, Lin Xu, Xiaoqing Lu, Huanyu Wang, Bin Wang, Guodong Liang	1
6	Population Attributable Risks of Potential Modifiable Factors for Atrial Fibrillation in China: A National Survey 2022 ·Risk Management and Healthcare Policy ·Zhiqiang Nie, Hongbin Xu, Chen Chen, Yong Gan, Guo Chen, Chao Wang, Wei Yue, Feng Yan, Yingqing Feng, Zuxun Lu	3
7	Complete Cytoreductive Surgery vs. Debulking Surgery for pseudomyxoma peritonei of appendiceal origin: A propensity score-matched study based on a single-center experience 2021 ·European Journal of Surgical Oncology ·(unknown), (unknown), Bing Wang, (unknown), (unknown), (unknown), (unknown), Ying Cai, (unknown), (unknown), Feng Chen, Hongbin Xu	11
8	Pseudomyxoma peritonei originating from intestinal duplication: A case report and review of the literature 2021 ·World Journal of Clinical Cases ·(unknown), Nan Zhou, (unknown), Hongbin Xu, (unknown), (unknown)	3
9	The global prevalence of turnover intention among general practitioners: a systematic review and meta-analysis 2020 ·BMC Family Practice ·(unknown), Heng Jiang, Hongbin Xu, Jun Ye, Chuanzhu Lv, Zuxun Lu, Yong Gan	40
10	Discrepancy in perceived social support and related factors among Chinese college students with and without siblings 2020 ·Journal of Affective Disorders ·Hongbin Xu, Shijiao Yan, Yuanyuan Chang, Heng Jiang, Li Zou, Yong Gan, Yanhong Gong, Shiyi Cao, Chao Wang, Junan Liu, Zuxun Lu	5
11	Are long working hours associated with weight‐related outcomes? A meta‐analysis of observational studies 2019 ·Obesity Reviews ·Yi Zhu, Jianxin Liu, (unknown), Heng Jiang, Tracey Brown, Qingfeng Tian, Yudi Yang, Chao Wang, Hongbin Xu, Junan Liu, Yong Gan, Zuxun Lu	11
12	An immunocompetent rat model of infection with Cryptosporidium hominis and Cryptosporidium parvum 2019 ·International Journal for Parasitology ·(unknown), Abhineet S. Sheoran, (unknown), Hongbin Xu, Gillian Beamer, Giovanni Widmer, Saul Tzipori	9
13	Diagnosis and treatment of ankle syndesmosis injuries with associated interosseous membrane injury: a current concept review 2019 ·International Orthopaedics ·(unknown), (unknown), Guosheng Xiong, Hongbin Xu, (unknown)	22
14	Urachal mucinous adenocarcinoma with pseudomyxoma peritonei 2017 ·Medicine ·(unknown), Nan Zhou, Hongbin Xu, (unknown), (unknown), Fang Li, (unknown)	10
15	Guggulsterone of Commiphora mukul resin reverses drug resistance in imatinib-resistant leukemic cells by inhibiting cyclooxygenase-2 and P-glycoprotein 2014 ·Phytomedicine ·Hongbin Xu, (unknown), (unknown), (unknown)	10
16	Reversion of Multidrug Resistance in a Chemoresistant Human Breast Cancer Cell Line by β-Elemene 2012 ·Pharmacology ·Hongbin Xu, Ling Li, (unknown), (unknown), (unknown)	41
17	Reversion of P-glycoprotein-mediated multidrug resistance by guggulsterone in multidrug-resistant human cancer cell lines 2012 ·European Journal of Pharmacology ·Hongbin Xu, (unknown), Ling Li, (unknown), (unknown)	22
18	Reversal of Multidrug Resistance by Guggulsterone in Drug-Resistant MCF-7 Cell Lines 2011 ·Chemotherapy ·Hongbin Xu, Ling Li, Guoqing Liu	21
19	Aromatase Inhibitor Versus Tamoxifen in Postmenopausal Woman With Advanced Breast Cancer: A Literature-Based Meta-Analysis 2011 ·Clinical Breast Cancer ·Hongbin Xu, Yujin Liu, Ling Li	20
20	A literature-based meta-analysis taxane-based doublet versus single-agent taxane chemotherapy in patients with advanced breast cancer 2010 ·Journal of Cancer Research and Clinical Oncology ·Hongbin Xu, Qing Xu, Ling Li	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact